In recent months, DMRF Canada has received an increasing number of inquiries from dystonia patients about the efficacy of medical marijuana for the treatment of dystonia and other movement disorders. The research in this area is still inconclusive, with more studies on the way. Our Spring 2018 Newsletter included an article about what we now so far. Please find a list of sources below:
What's Making News
March 27, 2018 - 9:41am
"We are very excited to serve as the home of the first Clinical Fellowship for Movement Disorders supported by Allergan Canada. The committee couldn't have selected a better candidate than Dr. Lizarraga, a bright, enthusiastic, inquisitive and dedicated young movement disorders trainee who will definitely make the most of this support and will make the Canadian dystonia community proud." - Dr. Anthony Lang, Toronto Western Hospital
March 5, 2018 - 10:25am
This past month, members of the the DMRF Medical and Scientific Advisory Committee (MSAC) representing key opinion leaders in movement disorders, neuroscience and related fields met in Texas to offer their guidance on future research directions and priorities.
March 1, 2018 - 2:13am
As a proud member of Neurological Health Charities Canada (NHCC), DMRF Canada is pleased to present an opinion piece in the Globe and Mail that speaks to the urgent need for additional research funding and more supports provided to individuals dealing with neurological conditions in Canada. Read the article here.
February 27, 2018 - 9:37am
Cervical dystonia is a focal dystonia that affects the head and neck. Cervical dystonia produces excessive muscle contractions in the neck. These muscle contractions cause involuntary, repetitive movements and awkward positions of the head, neck, and sometimes shoulders.
Cervical dystonia is sometimes referred to as spasmodic torticollis.
Cervical dystonia may cause: